Targeting CPS1 attenuates lung cancer metastasis by regulating EMT through an epigenetic mechanism
Theranostics · 2026
DOI: 10.7150/thno.123679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Yi Ding und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University; Shanghai, 200241, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Epithelial-Mesenchymal Transition, Epigenesis, Genetic, Carbamoyl-Phosphate Synthase (Ammonia). Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Metastasis is the primary cause of cancer-related mortality, and targeting the drivers of this process is a promising strategy to improve patient outcomes. Recent studies have highlighted a role of Carbamoyl Phosphate Synthetase 1 (CPS1), the urea cycle's rate-limiting enzyme, in tumor development. However, its involvement in tumor spreading and metastasis remains unclear.
Methods
Transwell assay, wound healing assay and a range of lung cancer metastasis animal models were employed to investigate the impact of genetic knockdown and pharmacological inhibition of CPS1 on lung cancer metastasis both in vitro and in vivo. Quantitative proteomic analysis, RNA sequencing, untargeted metabolomics and targeted metabolomics to urea cycle were conducted to elucidate the underlying mechanisms of CPS1 inhibition.
Results
CPS1 was overexpressed in a subset of patients with metastatic lung cancer, and this increased expression correlated with decreased patient survival. Genetic knockdown and pharmacological inhibition of CPS1 significantly reduced the tumor burden and metastasis in mice with the spontaneous (Kras G12D/+; p53 -/-) and induced metastatic lung cancer. Mechanistically, CPS1 overexpression in metastatic cancer cells resulted in excessive fumarate production, an intermediate metabolite in the urea cycle. Fumarate accumulation inhibited TET2 activity and altered miR200a gene methylation to drive epithelial-to-mesenchymal transition (EMT), thereby enhancing cell migration and invasion. Notably, CPS1 inhibition reduced fumarate accumulation and enhanced TET2 activity, which epigenetically upregulated PD-L1 expression. This activation contributed to impaired CD8⁺ T cell function and ultimately promoted tumor immune evasion. To overcome immune evasion, we investigated a combination therapy. Combining a CPS1 inhibitor with an anti-PD-1 antibody demonstrated a synergistic and potent effect, significantly inhibiting both lung tumor growth and metastasis.
Conclusions
These findings define a crucial role for CPS1 in lung cancer metastasis. Targeting CPS1 may offer a valuable therapeutic intervention strategy against metastatic lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University; Shanghai, 200241, China.
- Jiangong Hospital Clinical Research Center, East China Normal University; Shanghai, 200241, China.
- Durbrain Medical Laboratory; Hangzhou, 310000, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Interventional Oncology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200001, China.
- Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zitieren
APA
Ding, Y., Tian, Y., Li, M., Fu, Y., Wang, T., Du, X., Wang, M., Dong, L., Gao, F., Liu, B., Lu, Y., Zhang, C., Mao, L., Jiang, J., Li, L., Liao, L., & Li, K. (2026). Targeting CPS1 attenuates lung cancer metastasis by regulating EMT through an epigenetic mechanism. Theranostics. https://doi.org/10.7150/thno.123679
Vancouver
Ding Y, Tian Y, Li M, Fu Y, Wang T, Du X, et al. Targeting CPS1 attenuates lung cancer metastasis by regulating EMT through an epigenetic mechanism. Theranostics. 2026. doi:10.7150/thno.123679
BibTeX
@article{Ding2026,
author = {Ding, Yi and Tian, Yuying and Li, Mengjuan and Fu, Yunyun and Wang, Tingting and Du, Xiaoyao and Wang, Mingming and Dong, Lele and Gao, Fei and Liu, Bei and Lu, Yunhan and Zhang, Chenfei and Mao, Lin and Jiang, Jinhua and Li, Lei and Liao, Lujian and Li, Kun},
title = {Targeting CPS1 attenuates lung cancer metastasis by regulating EMT through an epigenetic mechanism},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.123679}
}
EUVIMED